**GLP Therapies Are Not Weight-Loss Drugs. They Are Rewriting Metabolic Medicine.** Pause for a second
Abstract Peptides have gained so much attention in the last decade that they are now part of the main strategies, with small molecules and biologics, for developing new medicines
Yet even advocates for the drugs use acknowledge uncertainty about how long it would take for such health benefits to kick in, or whether shorter-term use would prevent or ameliorate longer-term illnesses
Additive effects of mitochondrion-targeted cytochrome cyp2e1 and alcohol toxicity on cytochrome c oxidase function and stability of respirosome complexes *
Diabetes: L-Carnitine may improve insulin sensitivity and glucose metabolism in people with diabetes, and has been studied for its potential to reduce complications associated with the condition
Wen Q, Zhang L, Zhao F, Chen Y, Su Y, Zhang X